DOBOT (SEHK: 02432) shares are up more than 7% in trading today.

As of the time of writing, the stock has risen 7.22% to HK$26.42, with a turnover of HK$64.75 million.

The company recently announced that it has instructed a trustee to initiate a share purchase program.

It will utilize special funds from an incentive plan to buy its own H-shares on the secondary market at prevailing prices to implement an H-share incentive scheme.

The total cost for this share purchase is expected not to exceed HK$200 million.

On the evening of June 26, the company disclosed that between June 25 and June 26, the trustee had already purchased a total of 300,200 H-shares from the market.

These shares are being held in trust for the benefit of eligible participants under the terms of the H-share incentive plan.

Analysts have previously highlighted that DOBOT is a rare entity that combines a leading global position in collaborative robots with full-stack in-house R&D capabilities in embodied AI.

Looking ahead, the company's collaborative robot arm business is anticipated to enter a phase of multiple positive catalysts by 2026.

This period is expected to feature new product volume growth, customer repurchases, capacity expansion, and profitability improvements.

Concurrently, its embodied AI business has clear shipment targets and is accelerating its path to commercialization.

Revenue forecasts for 2026 to 2028 have been raised to 750 million, 1.08 billion, and 1.53 billion yuan respectively.

This corresponds to year-on-year growth rates of 52%, 45%, and 41% for those years.

It is noted that DOBOT's current valuation shows a significant discount compared to its peer, South Korea's Doosan Robotics.

The potential advancement of a secondary listing on China's A-share market is seen as a catalyst that could drive a re-rating of the company's valuation.